All Stories

  1. Clinical vs. statistical significance: considerations for clinical laboratories
  2. The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures
  3. The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures
  4. Ensuring quality in 17OHP mass spectrometry measurement: an international study assessing isomeric steroid interference
  5. The LEAP checklist for Laboratory Evaluation and Analytical Performance characteristics reporting of clinical measurement procedures
  6. The LEAP Checklist for Laboratory Evaluation and Analytical Performance Characteristics Reporting of Clinical Measurement Procedures
  7. The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures
  8. The LEAP checklist for Laboratory Evaluation and Analytical Performance Characteristics reporting of clinical measurement procedures
  9. The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures
  10. The LEAP checklist for laboratory evaluation and analytical performance characteristics reporting of clinical measurement procedures
  11. Endogenous isobaric interference on serum 17 hydroxyprogesterone by liquid chromatography-tandem mass spectrometry methods
  12. Method evaluation in the clinical laboratory
  13. Testosterone and exercise: effects on fitness, body composition, and strength in middle-to-older aged men with low-normal serum testosterone levels
  14. Effects of testosterone treatment, with and without exercise training, on ambulatory blood pressure in middle‐aged and older men
  15. Relationship between visceral adipose tissue and bone mineral density in Australian baby boomers
  16. Influence of isotopically labeled internal standards on quantification of serum/plasma 17α-hydroxyprogesterone (17OHP) by liquid chromatography mass spectrometry
  17. U‐shaped association of vigorous physical activity with risk of metabolic syndrome in men with low lean mass, and no interaction of physical activity and serum 25‐hydroxyvitamin D with metabolic syndrome risk
  18. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study
  19. Low 25-Hydroxyvitamin D Concentration Is Not Associated With Refractive Error in Middle-Aged and Older Western Australian Adults
  20. Vitamin D and respiratory health in the Busselton Healthy Ageing Study
  21. Serum 25-hydroxyvitamin D as a predictor of mortality and cardiovascular events: A 20-year study of a community-based cohort
  22. 25-Hydroxyvitamin D C3-epimer is universally present in neonatal Western Australian samples but is unlikely to contribute to diagnostic misclassification
  23. Vitamin D and respiratory health in the Busselton healthy ageing study
  24. Discordance between fat mass index and body mass index is associated with reduced bone mineral density in women but not in men: the Busselton Healthy Ageing Study
  25. Debrisoquine Metabolism and CYP2D Expression in Marmoset Liver Microsomes
  26. Improved plasma free metadrenaline analysis requires mixed mode cation exchange solid-phase extraction prior to liquid chromatography tandem mass spectrometry detection
  27. Hormone measurement techniques and problems with LC-MS/MS